Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide

Lookup NU author(s): Professor Ruth PlummerORCiD, Professor Alan Boddy, Professor Nicola CurtinORCiD, Emeritus Professor Herbie Newell, Lynsey Robson, Professor Hilary Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Plummer ER, Middleton M, Wilson R, Evans J, Jones C, Olson A, Boddy AV, Curtin NJ, Kaufman R, Harris A, Johnston P, Newell DR, Robson L, Dewji R, Calvert AH

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics

Year of Conference: 2005

Pages: 9099S-9099S

ISSN: 1078-0432

Publisher: Clinical Cancer Research: American Association for Cancer Research

Notes:

Library holdings: Search Newcastle University Library for this item

ISBN:

Share